News and Trends 13 Jul 2023 Partnership to progress neurodegenerative disorder treatments …via the Tau Consortium, and the expertise of Weill Cornell Medicine neuroscientist Li Gan to pursue innovative therapies for neurodegenerative disorders. Neurodegenerative disorders include dementias, Parkinson’s disease, Alzheimer’s disease (AD),… July 13, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Startup Scout 16 Mar 2018 This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases …few or no alternatives exist, as is the case in Alzheimer’s. An effective biomarker may help bring a successful drug for Alzheimer’s disease to the market. Image by ANADMAN BVBA/Shutterstock… March 16, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 30 Nov 2016 Drugging the Undruggable: New Acquisition to Boost GPCR Drugs …up to 30% of approved drugs and can hold the key to treating many diseases, ranging from Alzheimer’s to cancer. However, their conformational flexibility in solution is a huge challenge… November 30, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 31 Mar 2023 €260M fund addresses dementia investment shortfall …in NewAmsterdam Pharma, which focuses on cardiovascular and Alzheimer’s disease, in January 2021, the fund has since invested in four companies. One is Muna Therapeutics, which specializes in Alzheimer’s disease… March 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 19 Sep 2024 Mitochondrial disease treatments: is a breakthrough on the horizon? …called sporadic inclusion body myositis. Also known as the ‘Alzheimer’s of the muscle’ owing to the buildup of the same proteins that are hallmarks of Alzheimer’s in muscles, the root… September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 May 2019 Top 10 Biotechs in Lausanne …of Alzheimer’s, and the company has a variety of other antibodies and vaccines under investigation for the disease. However, Alzheimer’s is far from the company’s only focus. With a broad… May 8, 2019 - 7 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2024 Booster launches to treat neurodegenerative diseases with proteasome activation …like Parkinson’s and Alzheimer’s. “We’re starting in neurodegenerative diseases, such as Parkinson’s and Alzheimer’s. We know that proteasome dysfunction is present in these diseases, and multiple pathways are going wrong,… October 15, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jun 2021 Scotland’s Top 10 Biotech Companies to Watch Out For …patients given the drug as a monotherapy. Results from another phase III trial of the same drug in Alzheimer’s patients are expected next year. The Alzheimer’s disease field has seen… June 30, 2021 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Dec 2018 Looking Back on 2018: Our 10 Most Popular Interviews …effects. 7. Meet the Swiss CEO pulling out all the stops against Alzheimer’s disease Efforts to treat Alzheimer’s disease have been hit with failure after failure in the last year… December 24, 2018 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jan 2025 Curing ALS? Sixteen companies developing new treatments in 2025 …as C9orf72 in ALS and frontotemporal dementia. As of now, its ALS treatment is in the discovery phase, along with two other programs focused on Parkinson’s and Alzheimer’s. As its… January 22, 2025 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2024 Eight areas where gene therapy shines …decline, gene silencing techniques are being investigated to reduce the expression of the mutant huntingtin protein responsible for neuronal damage. Similarly, in Alzheimer’s disease, strategies are being developed to target… November 21, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 12 Mar 2018 A Flick of a Switch Can Cause Age-Related Brain Deterioration …age, these stem cells lose their capacity to repair the brain. The loss of nerve cells is one of the key features of neurodegenerative diseases like Alzheimer’s. The Cambridge-based researchers… March 12, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email